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Abstract
Background: Invasive urodynamics is used to investigate the causes of lower urinary tract symptoms; a procedure
usually conducted in secondary care by specialist practitioners. No study has yet investigated the feasibility of
carrying out this procedure in a non-specialist setting. Therefore, the aim of this study was to explore, using
qualitative methodology, the feasibility and acceptability of conducting invasive urodynamic testing in primary care.
Methods: Semi-structured interviews were conducted during the pilot phase of the PriMUS study, in which men
experiencing bothersome lower urinary tract symptoms underwent invasive urodynamic testing along with a series
of simple index tests in a primary care setting. Interviewees were 25 patients invited to take part in the PriMUS
study and 18 healthcare professionals involved in study delivery. Interviews were audio-recorded, transcribed
verbatim and analysed using a framework approach.
Results: Patients generally found the urodynamic procedure acceptable and valued the primary care setting due to
its increased accessibility and familiarity. Despite some logistical issues, facilitating invasive urodynamic testing in
primary care was also a positive experience for urodynamic nurses. Initial issues with general practitioners receiving
and utilising the results of urodynamic testing may have limited the potential benefit to some patients. Effective
approaches to study recruitment included emphasising the benefits of the urodynamic test and maintaining
contact with potential participants by telephone. Patients’ relationship with their general practitioner was an
important influence on study participation.
Conclusions: Conducting invasive urodynamics in primary care is feasible and acceptable and has the potential to
benefit patients. Facilitating study procedures in a familiar primary care setting can impact positively on research
recruitment. However, it is vital that there is a support network for urodynamic nurses and expertise available to
help interpret urodynamic results.
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Background
Lower urinary tract symptoms (LUTS) are highly preva-
lent amongst men aged over 40, with over 70% reporting
at least one symptom [1], and are associated with re-
duced emotional wellbeing, productivity, and quality of
life [2, 3]. Urodynamics is a specialist test for investigat-
ing the causes of LUTS [4]. It is typically conducted in
secondary care and involves inserting catheters into the
bladder and rectum to enable measurements pertaining
to bladder function. A growing number of patients pre-
senting with LUTS are eventually treated conservatively
and thus could potentially be effectively managed in pri-
mary care [5, 6]. Managing LUTS in primary care set-
tings could result in benefits for the patient and cost
benefits for the NHS. However, general practitioners
(GPs) currently do not have access to simple tools to ac-
curately diagnose the cause of LUTS in men.
Recognising this issue, the UK National Institute for
Health Research (NIHR) released a Health Technology
Assessment (HTA) commissioned call for the develop-
ment of a clinical decision aid to help inform treatment
choice or need for specialist referral for men presenting
with LUTS in primary care. The PriMUS study (‘Primary
care management of lower urinary tract symptoms in
men: development and validation of a diagnostic and
clinical decision support tool’) addresses this brief [7].
PriMUS is a prospective diagnostic accuracy study based
in UK primary care settings. Participants undergo simple
index tests together with invasive urodynamics as a ref-
erence standard, to determine the combination of index
tests that best predicts common urodynamic diagnoses.
This will inform the development of a clinical decision
support tool for use by GPs with their patients.
Invasive urodynamics is a complex procedure with risk
of adverse effects, yet very few qualitative studies have
explored patient acceptability of this test. One interview
study [8] found patients experienced anxiety and embar-
rassment about the procedure, which was alleviated by
healthcare professionals through effective interpersonal
and communication skills. Previously, men participating
in a randomised controlled trial involving urodynamics
[9] found the procedure acceptable and valued the com-
prehensive insight into their symptoms. As healthcare
professionals have been found to play an important role
in the patient experience of urodynamics [8, 9], it is im-
portant to further explore their perspectives. Further-
more, no study has explored in-depth the attitudes of
patients who have declined urodynamics, who may view
the procedure differently [9].
PriMUS is the first large-scale study to implement in-
vasive urodynamics in a primary care setting; no study
has yet investigated the feasibility and acceptability of
conducting this procedure in a non-specialist setting.
This study aimed to explore in-depth the feasibility and
acceptability of providing invasive urodynamics in pri-
mary care, including experiences of recruiting to a uro-
dynamic study, encompassing the perspectives of
patients (including those who declined the procedure)
and healthcare professionals. Including these participant
groups provided further insight into attitudes towards
and experiences of urodynamics, and the feasibility of
providing urodynamics in primary care, and sought to
inform processes or interventions that could improve ac-
ceptability of this invasive procedure. Given the explora-
tory nature of the research, a qualitative approach was
needed to enable detailed insight into participant experi-
ences that could not be obtained via quantitative
methods such as questionnaires. The qualitative study
was conducted during the pilot phase of the PriMUS




This qualitative study was part of the larger PriMUS
study, which gained ethical approval from Wales Re-
search Ethics Committee 6. PriMUS is recruiting
adult men presenting to their GP with one or more
bothersome LUTS, in approximately 90 GP practices
across Newcastle upon Tyne, South Wales and Bristol
(see study protocol [7] for full inclusion and exclusion
criteria). Participants to date underwent a series of
index tests together with invasive urodynamics, which
is usually carried out in secondary care by specialist
practitioners. In the PriMUS study, the procedure was
performed by trained research nurses in primary care
settings. Results of the urodynamic procedure and
index tests were uploaded to an online database,
quality-checked and reviewed by clinical scientists and
urologists on the study team (AB, MD, CH and
MJD), and a summary of results for GPs was com-
piled manually. This included the likely diagnosis(es)
and a flowchart of management recommendations
based on the National Institute for Health and Care
Excellence (NICE) guidelines [10].
Before conducting urodynamics as part of the study,
research nurses were provided with a urodynamics man-
ual and underwent a series of training activities to en-
sure competency, including completing an accredited
urodynamic training course overseen by study urologists,
shadowing urologists in secondary care settings and
completing study specific interpretation and equipment
training. They receive frequent, ongoing peer and clin-
ical support from members of the study management
team and have access to a named Urology Champion in
each study region.
Qualitative methods such as interviews are particularly
appropriate to increase understanding of patient
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experiences of trial processes [11] and can allow for the
exploration of previously unanticipated issues that may
be missed in quantitative studies. Therefore, semi-
structured telephone interviews were conducted with
men invited to take part in the main PriMUS study.
Telephone and face-to-face interviews were also carried
out with healthcare professionals involved in study deliv-
ery, including GPs and practice nurses involved in study
recruitment, and research nurses who performed the
urodynamic procedure.
Sampling and recruitment
Purposive sampling was used to support maximum vari-
ation in terms of study site, decision to participate in the
main PriMUS study (for patients) and role in study de-
livery (for healthcare professionals). Patients invited to
participate in the main study could indicate whether
they consented to be contacted for a follow-up interview;
this included both patients who consented to the main
study and those who declined to participate. Patients
consenting to be contacted were invited to take part in
an interview once they had undergone all study proce-
dures or had made the decision not to participate in the
main PriMUS study. Interview participants were offered
a £10 voucher for their contribution. Healthcare profes-
sionals were approached to take part once they had ex-
perience of study processes (e.g. recruiting patients or
performing urodynamics). Recruitment continued until
data saturation was reached. Informed consent (written
or verbal) was obtained for all face-to-face and telephone
interviews after participants had sufficient time to read
the interview study information sheet.
Data collection
Semi-structured interview topic guides were developed
in consultation with clinicians and patient representa-
tives on the study team. Topics explored in patient
interviews included thoughts about the main study infor-
mation, the decision of whether to take part, concerns
about the study and how others could be encouraged to
participate. Those participating in the main study were
also asked about their experience of study processes and
specifically the urodynamic test. Topics covered in
healthcare professional interviews included (as applic-
able) experiences of study recruitment, perceived patient
acceptability of study processes, staff experiences of per-
forming the urodynamic test and the feasibility of doing
so in primary care. Topic guides were developed itera-
tively throughout the data collection period to allow for
the exploration of previously unanticipated themes aris-
ing from the interviews. For example, after issues relat-
ing to urodynamic test results were highlighted by GPs,
this was specifically explored in subsequent interviews.
Interviews were conducted between May 2018 and
February 2019. Most were conducted by SM, an experi-
enced qualitative health researcher, with the remainder
conducted by medical students (EC, RH and FM) super-
vised by SM. To encourage respondents to give honest,
unbiased feedback about their experience of the main
study, the interviewers were not previously known to
participants and had no involvement in main study pro-
cedures. All interviews were audio-recorded and tran-
scribed verbatim for analysis.
Analysis
A framework approach [12] was used to analyse inter-
view data. SM compiled a list of key categories to ex-
plore, with reference to the interview topic guide: (1)
acceptability of invasive urodynamics in primary care,
(2) feasibility of invasive urodynamics in primary care
and (3) experiences of recruiting to a urodynamic study.
After reading through transcripts, emergent sub-themes
were identified within these three categories in the initial
framework. Analysis was an iterative process, enabling
interviews to continue until saturation was reached. Sat-
uration was determined as being achieved once inter-
views resulted in no new themes and when detailed data
had been collected relating to each identified theme. SM
entered a framework of categories and sub-themes into
NVivo V11 (QSR International), then uploaded and
coded interview transcripts. Ten percent of transcripts
was independently coded by NJW, and coding was com-
pared and discussed to ensure inter-rater consistency.
Sub-themes were refined throughout the coding process
to ensure they captured the diversity of participants’ ex-
periences. Once all interviews were coded, SM compiled
tables to show a summary of each participant’s responses
in relation to each category and sub-theme. Tables in-
cluded data extracts from the coded interview tran-
scripts; this enabled the validity of the proposed themes
to be reviewed by SM and NJW, ensuring that there
were sufficient data to support each of the emergent
sub-themes, and that they provided an accurate reflec-
tion of participant experiences.
Results
Interviews were conducted with 25 male patients and 18
healthcare professionals, from 22 GP practices across
Newcastle upon Tyne, South Wales and Bristol (Table 1).
Interviews with patients lasted between 8 and 44 min
(mean 23.0); interviews with healthcare professionals
lasted between 9 and 30 min (mean 18.8). Eight sub-
themes were identified under the three main framework
categories: Acceptability of invasive urodynamics in pri-
mary care (three sub-themes), feasibility of invasive uro-
dynamics in primary care (three sub-themes) and
recruiting to a urodynamic study (two sub-themes) (see
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Table 2). Participant quotes are labelled with a unique
participant identification number, with the prefix MSP for
patients who participated in the main study, IP for pa-
tients who participated in the interview element only, GP
for general practitioners and UN for urodynamic nurses.
Acceptability of invasive urodynamics in primary care
Apprehension and embarrassment
All patients who underwent urodynamics reported find-
ing the procedure acceptable, with most finding it as
they had expected, or better than expected. Around half
reported discomfort, although this was universally de-
scribed as brief or mild. Some patients described feeling
apprehensive about the test; those with experience of
similar medical procedures (e.g. cystoscopy) reported
lower anxiety. The invasive nature of the procedure was
mentioned by several patients; some commented that
this was not an issue for them, while others found it
embarrassing, particularly where the procedure was con-
ducted by female healthcare professionals. While one
suggested this was due to his older age, another ex-
plained how he accepted that getting older meant inva-
sive procedures were more likely (Table 3).
Communication
A key factor in patient acceptability was the extent to
which nurses explained the test, supported patients with
information provision in advance and through the pro-
cedure and made them feel at ease. Patients reported
they had been given the right level of information, so
understood the purpose of the test, and that the nurses
made the procedure as comfortable as possible, which
reduced their anxiety. The ‘respectful’ and ‘professional’
manner of nurses in discussing and conducting uro-
dynamics also helped to reduce patient embarrassment.
Preference for primary care
Undergoing the urodynamic test in primary rather than
secondary care was viewed positively by patients, mainly
due to convenience (e.g. reduced waiting and travel time
and ease of parking) and familiarity with surgery staff.
Several patients explained they had ‘full confidence’ in
their GP practice and felt relaxed about visiting the sur-
gery, while they would be more apprehensive if they had
to attend hospital for the same procedure (Table 4).
Some suggested that they would not have agreed to
undergo urodynamics if the test had been conducted in
hospital.
Feasibility of invasive urodynamics in primary care
Training and support
Urodynamic nurses reported that facilitating urodynam-
ics in primary care was generally a positive experience.
Most had not independently performed invasive uro-
dynamics before receiving training for the PriMUS study
and were apprehensive about conducting the procedure
in a community setting, but all felt their confidence grew
Table 1 Participant characteristics
Patients (n = 25) Healthcare professionals (n = 18)
N N
Participant in main study Role
Yes 22 GP 11
No 3 Practice nurse 3
Urodynamic nurse 4
Geographical region Geographical region
Newcastle upon Tyne 10 Newcastle upon Tyne 6
South Wales 9 South Wales 7






aParticipant age was not recorded for patients who did not participate in the
main PriMUS study
Table 2 Key framework categories and emergent sub-themes
Key framework categories Emergent sub-themes
Acceptability of invasive urodynamics in primary care Apprehension and embarrassment
Communication
Preference for primary care
Feasibility of invasive urodynamics in primary care Training and support
Logistical issues
Difficulties receiving and using results
Recruiting to a urodynamic study Importance of proactive recruitment
Reasons for participation and non-participation
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as they gained experience. They valued the initial train-
ing and ongoing support provided by the study team,
particularly regular teleconferences with peers and ac-
cess to ad-hoc telephone advice.
Logistical issues
Several logistical issues related to performing urodynam-
ics in primary care were identified. Facilities at GP prac-
tices varied, and the procedure was sometimes carried
out in unsuitable rooms, for example with a carpeted
floor that was difficult to clean, insufficient space or dif-
ficulty accessing a sluice. Remote working meant nurses
had to transport heavy equipment and sometimes expe-
rienced internet connectivity issues, which had led to
clinic cancellations.
Difficulties receiving and using results
GPs highlighted problems with receiving and utilising
urodynamic results in the initial stages of the study.
Study-specific quality assurance procedures meant GP
summaries took longer to be returned than expected,
and where concurrent diagnoses were identified, GPs
were unsure which to treat first. It was suggested this
limited the potential benefit of the study to some pa-
tients (Table 5). As GP interviews were conducted in the
pilot phase of the PriMUS study, their feedback enabled
changes to be made to site training and the process of
obtaining results.
Recruiting to a urodynamic study
Importance of proactive recruitment
Main study recruitment was opportunistic or via primary
care database searches, with most GP practices using a
combination of these approaches. Healthcare profes-
sionals emphasised the importance of having a recruit-
ment lead at each practice, to ensure database searches
Table 3 Acceptability of invasive urodynamics in primary care
Apprehension and embarrassment:
It was a little bit… uncomfortable at first, but I mean not greatly so… It
was only two seconds… I was a little bit… nervous because I didn’t know
how painful it was going to be. But it was actually… nothing like what I
thought it was going to be you know. It was… a lot nicer or better…
(MSP 2015, age 65)
She explained it was going to feel a bit uncomfortable when they did it,
and it did, it tingled a bit but that was about it, it was very much as I
expected. (MSP 1023, age 73)
No concerns at all really… I’d had that camera or catheter, or whatever
you call it, in my bladder twice before. So, I, it didn’t put me off at all. (MSP
3103, age 74)
My biggest problem … I did feel embarrassed with some of the procedure,
you know… [I’m] old fashioned, that’s the trouble. (MSP 1117, age 84)
If you’re male and you’ve got three women… you know it’s a bit
embarrassing… I just convinced myself like you’re an old man now, you
know, they see these things all the time. So I managed to rationalise
that… and I realise as I get older you might have to put up with more of
that stuff. (MSP 1025, age 57)
MSP main study participant
Table 4 Acceptability of invasive urodynamics in primary care
Communication:
They explained everything well… I thought it was quite an uncomfortable
test and quite deep. But… they were very professional, the way they talked
about it and dealt with it… they were friendly, they spoke to you during it,
you know, you weren’t just like lay there… they tried to make you as
comfortable as possible. (MSP 2002, age 55)
I found it quite easy, really, with the people I saw, you know, all the way
through… That was nice not to have to worry about the people… you
knew that they were explaining it to you and helping you, and guiding
you, really. (MSP 3103, age 74)
I was a bit worried at the start… but the girls that did it were, made you
feel at ease and were brilliant, so I didn’t really feel under any pressure.
(MSP 3110, age 56)
Preference for primary care:
I [can’t] see any benefit [to having the test done in hospital], I think it was
better at my doctors, it was a lot more relaxed, because obviously I knew
the nurse and I knew the doctor and you know, I had chatted with them
about the test. (MSP 2002, age 55)
It saved me going to hospital and… getting a taxi and one thing and
another. I think that’s more why I did it sort of thing I think at the doctors
rather than traipsing round the country. (MSP 3110, age 56)
It’s more personal with the doctor. And he knows your history and that.
(MSP 2006, age 77)
MSP main study participant
Table 5 Feasibility of invasive urodynamics in primary care
Training and support:
It was difficult to begin with and I like being challenged so that was
interesting… Being able to go to the… urodynamics course was fantastic,
that was really, well essential but really, really interesting and useful as well
and the peer support that we get [from] the fortnightly nurse
teleconferences [was] particularly useful at the beginning. (UN 506)
We had issues on our very first patient and we were lucky that we’re able
to phone up… and say what shall we do about this… Having someone
on the end of the line is reassuring. (UN 607)
Logistical issues:
[The equipment is] heavy. It’s really bulky. And it’s sensitive equipment as
well… It’s been hard graft. You’ve got to get it all in the car, get it all
out… up hills and over steps and in to little rooms. So it’s not good for the
equipment. It’s not really good for my back [laughs]… It’s quite stressful…
making sure I’ve got every single thing to run the test. (UN 606)
We don’t always have the most appropriate room available to us in the GP
surgeries… Sometimes the rooms are tiny, and you literally are falling over
each other… sometimes the electricity sockets are not in the right place, so
we have to use our extension lead… there’s lots of sort of improvisation…
I think we manage it quite well, but it is a challenge. (UN 607)
Difficulties receiving and using results:
You tell [patients that urodynamics] is the gold standard of investigation…
And that it could help further… define what the problem is, and… target
treatment a bit better… However… I’ve never had to look at…
urodynamics or reports before. And therefore I feel what they’re actually
getting out of it is… some half-hearted interpretation of… what might be
the best management plan. So although they may be getting gold stand-
ard investigation, they’re not necessarily getting gold standard advice. (GP
604)
UN urodynamic nurse, GP general practitioner
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were carried out regularly and to remind others to re-
cruit opportunistically. Maintaining telephone contact
with patients invited to take part was highlighted as par-
ticularly effective in improving study recruitment and
retention.
Reasons for participation and non-participation
When explaining the study to patients, clinicians
emphasised they would have quicker access to a com-
prehensive diagnostic test not normally available in
primary care, that could help in the diagnosis and
treatment of their LUTS. Accordingly, most patients
identified this as a key factor in their decision to take
part. Another common reason for participation was
the altruistic opportunity to contribute to research
with the potential to improve medical practice and
benefit others in the future. Some participants specif-
ically desired to raise the profile of LUTS in men.
Others wanted to participate to help their own GP
surgery, particularly where they had built up a good
relationship with their GP. Conversely, one patient
who declined to take part in the main study explained
he was not familiar with any of the GPs at his sur-
gery. For patients who opted not to take part in the
study, this was mainly because they did not want to
have an invasive test. Those who participated appreci-
ated that the research could be carried out at a local
GP surgery, while those who declined generally mis-
takenly believed they would have to attend hospital
(Table 6).
To improve study recruitment, patients suggested
clinicians should emphasise that participants would
gain prompt access to a thorough assessment of their
symptoms without needing to go to hospital. Add-
itional reassurance about the urodynamic test was
recommended; for example, explaining that most pa-
tients who experience the test find it acceptable, or
giving a detailed timeline of the procedure to show
that discomfort associated with catheter insertion is
short-lived. Other suggestions included advertising the
research more widely, and particularly having the
study recommended by a familiar GP. Patients be-
lieved those who were uncomfortable with the
thought of the urodynamic test would not take part
in any instance.
Discussion
To the best of our knowledge, this is the first study
to explore the feasibility and acceptability of invasive
urodynamics in primary care, and the first qualitative
study of urodynamics to include the perspectives of
primary healthcare professionals. Overall, patients
found the urodynamic test acceptable; a key factor
in this was the extent to which nurses made them
feel well prepared and at ease, highlighting the im-
portance of good communication and the patient-
clinician relationship. Facilitating urodynamics in a
primary care setting benefitted patients, who valued
the convenience and familiarity of their GP practice.
Urodynamic nurses also found this to be a positive
experience, despite the logistical issues associated
with remote working, and felt well supported by the
study team. However, initial issues with receiving
and utilising the results of urodynamic testing may
have limited the potential benefit of the procedure
to some patients.
Approaches found to be effective in recruiting pa-
tients to the urodynamic study included having a re-
cruitment lead at each GP practice, maintaining
telephone contact with potential participants and
emphasising to patients that taking part would give
them quicker access to a thorough diagnostic test. Pa-
tients’ relationship with their GP was an important
influence on study recruitment; performing invasive
urodynamics in primary rather than secondary care
was also a key factor in encouraging participation. Pa-
tients suggested additional reassurance about the pro-
cedure would be helpful, particularly for those unsure
about taking part.
Table 6 Recruiting to a urodynamic study
Importance of proactive recruitment:
If you phone [the patient] a day or two beforehand, they’re more likely to
come in for [their study appointment] … Because, yeah, a couple of people
have said, you know if you didn’t phone I don’t think I’d be here. (UN 606)
Really you need somebody… leading the recruitment… making sure that
that database search is done, the list is checked, and the appropriate letter
sent out… Which… might slip off people’s radar a little bit if it’s not
something that’s done regularly. (GP 401)
Reasons for participation and non-participation:
I should benefit from it and so should other people. So to me, even though
it was a little bit intrusive the test, I still think it was for the right reasons…
just the knowledge that someone else may benefit from it, makes you feel
better. (MSP 2002, age 55)
[The doctor] said… the surgery [were] participating in the PriMUS study
and would I be prepared to take part and I said yes because he’s a
fabulous doctor. (MSP 1117, age 84)
I said yes, because it was at the surgery, had it… been at the hospital, I
would have said oh no… you’re talking an hour, an hour and a half one
way… but because it was round the corner to my house, it was totally
different. (MSP 2002, age 55)
I don’t like people prodding and poking around my private parts or
anything [laughs]… I thought no way am I letting them mess around with
me… because it’s not a very sort of, what shall we say, palatable thing is
it really? (IP 301)
I didn’t want [to do anything that] involved having to go to hospital… I
would prefer not to go to hospital… to do any testing at all… If the GP
wanted to do it, yes I don’t mind that. (IP 201)
UN urodynamic nurse, GP general practitioner, MSP main study participant, IP
interview-only participant
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The finding that invasive urodynamics is generally ac-
ceptable to patients supports quantitative studies [13,
14], which similarly report that most find the procedure
as or better than expected. As found in previous qualita-
tive research [8, 9], the interpersonal skills of nurses per-
forming urodynamics, along with good explanation of
the procedure, was key to patient acceptability. Building
on previous work [8], which found that attending hos-
pital to undergo urodynamics caused anxiety for older
patients, we found interview participants preferred
accessing the procedure in primary care. Findings also
add to currently limited research on the effect of
clinician-patient relationships on trial recruitment; as
found in questionnaire studies [15, 16], patients’ famil-
iarity with their GP appeared to influence their decision
to participate.
This study provides an in-depth exploration of an
under-researched area, adding new insights into pa-
tients’ acceptance of an invasive procedure in primary
care. A key strength is our large and diverse sample,
including the perspectives of primary healthcare pro-
fessionals which have not previously been explored.
Although we interviewed men across several geo-
graphical areas and of a wide range of ages, most
were aged over 50. Therefore, findings may not be
generalisable to younger men, who may experience
urodynamic testing differently [17, 18]. Furthermore,
we only interviewed three men who declined to take
part in the urodynamic study due to difficulties
recruiting participants from this group, so were un-
able to explore reasons for non-participation in detail.
Some interviews were brief, dependent on the extent
of participants’ involvement in the main PriMUS
study; however, the research aims were highly focused
and specific, enabling full examination of the research
issue. Although our overall sample size is comparable
to that obtained in similar qualitative studies (e.g. UP-
STREAM [9]), a larger quantitative study based on
this exploratory work would be useful to confirm
findings. All interviewers were female, and none were
qualified healthcare professionals, which may have af-
fected the extent to which male patients were willing
to discuss their experiences of urodynamic testing.
However, interview participants appeared comfortable
in disclosing detailed information about their experi-
ences and feelings.
Study findings indicate several recommendations for
future research and practice. Facilitating study proce-
dures where possible in local primary care settings
can result in increased participation rates and reduced
anxiety for patients, particularly where the invitation
to participate is from a familiar GP. More widely,
conducting invasive urodynamics in primary care may
encourage greater uptake of the procedure and reduce
the need for hospital referral. Findings may also apply
more widely to conducting urodynamics in commu-
nity settings. If implementing this in practice, it
would be important to ensure nurses performing uro-
dynamics are comprehensively trained and have access
to specialist advice. Having an experienced clinician
to interpret urodynamic results and provide a clear,
timely summary for GPs and patients is vital to en-
sure patients benefit fully from the invasive test. Ded-
icated space for urodynamics in a community hub
setting would help overcome the logistical difficulties
of transporting equipment and working in clinics with
varying facilities. Due to the invasive nature of the
urodynamic test, patients may benefit from additional
reassurance (e.g. via telephone) prior to the
procedure.
Future research could further explore the effects
on study recruitment of performing research proce-
dures in primary vs. secondary care settings and of
patients being invited to participate by their own GP
vs. other healthcare professionals. Greater explor-
ation of the perspectives of patients who decline in-
vasive urodynamics would provide a more rounded
insight into acceptability of the procedure. Including
the views of urodynamic nurses with a greater range
of experience would also allow more in-depth ex-
ploration of the feasibility of conducting urodynam-
ics in primary care.
Conclusions
Findings indicate that conducting invasive urodynam-
ics in primary care is feasible and acceptable to pa-
tients and healthcare professionals, and may
encourage uptake of the procedure. Facilitating study
procedures in familiar primary care settings can also
impact positively on research recruitment. Expertise
to help interpret urodynamic results, together with a
support network for urodynamic nurses working re-
motely, is essential to ensure the potential benefits of
the test are realised.
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